Active Ingredient History
Fluticasone furoate, sold under the brand name Flonase Sensimist among others, is a corticosteroid for the treatment of non-allergic and allergic rhinitis administered by a nasal spray. It is also available as an inhaled corticosteroid to help prevent and control symptoms of asthma. It is derived from cortisol. Unlike fluticasone propionate, which is only approved for children four years and older, fluticasone furoate is approved in children as young as two years of age when used for allergies. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Rhinitis, Allergic (approved 2007)
Skin Diseases, Eczematous (approved 1990)
Abdominal Injuries (Phase 2)
Adipose Tissue (Phase 2)
Airway Obstruction (Phase 4)
Allergy and Immunology (Phase 4)
Arthritis, Rheumatoid (Phase 1)
Asthma ()
Asthma, Exercise-Induced (Phase 3)
Biological Availability (Phase 1)
Blepharitis (Phase 2)
Body Contouring (Phase 2)
Body Weight (Phase 2)
Bronchial Spasm (Phase 4)
Bronchiectasis (Phase 4)
Bronchiolitis (Phase 2)
Bronchiolitis Obliterans (Phase 3)
Bronchitis (Phase 4)
Bronchitis, Chronic (Phase 4)
Candidiasis, Oral (Phase 4)
Carcinoma, Bronchogenic (Phase 2)
Conjunctivitis (Phase 4)
Conjunctivitis, Allergic (Phase 4)
COVID-19 (Phase 3)
Croup (Phase 3)
Deglutition Disorders (Phase 3)
Depression (Phase 4)
Dermatitis, Allergic Contact (Phase 2/Phase 3)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Early Phase 1)
Drug Evaluation (Phase 4)
Drugs, Investigational (Phase 1/Phase 2)
Eczema (Phase 1/Phase 2)
Emphysema (Phase 4)
Eosinophilic Esophagitis (Phase 4)
Eosinophils (Phase 2/Phase 3)
Esophagitis (Phase 2)
Eustachian Tube (Phase 2)
Exercise (Phase 4)
Glaucoma, Open-Angle (Phase 4)
Graft vs Host Disease (Phase 2)
Healthy Volunteers (Phase 4)
Hematopoietic Stem Cell Transplantation (Phase 3)
Hypersensitivity (Phase 4)
Hypertension (Phase 1)
Hypertrophy (Phase 4)
Inflammation (Phase 2/Phase 3)
Intestinal Neoplasms (Phase 2/Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Lung Diseases (Phase 3)
Lung Diseases, Obstructive (Phase 4)
Nasal Polyps (Phase 4)
Ocular Hypertension (Phase 4)
Osteoarthritis, Knee (Phase 2)
Otitis Media with Effusion (Phase 4)
Pharmacokinetics (Phase 2)
Pseudomonas aeruginosa (Phase 2)
Pseudomonas Infections (Phase 2)
Psoriasis (Phase 4)
Quality of Life (Phase 4)
Respiratory Sounds (Phase 4)
Rhinitis (Phase 4)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Perennial (Phase 4)
Rhinitis, Vasomotor (Phase 3)
Sinusitis (Phase 3)
Skin Diseases (Phase 4)
Sleep Apnea, Obstructive (Phase 4)
Steroids (Phase 4)
Tachyphylaxis (Phase 4)
Therapeutic Equivalency (Phase 1)
Thyroid Gland (Phase 2)
Urinary Tract Infections (Phase 2)
Vitiligo (Phase 4)
Vocal Cord Dysfunction (Phase 1)
Voice Disorders (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue